<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srv="http://cushingcef.com/20260710"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="srv-20260710.xsd" xlink:type="simple"/>
    <context id="AsOf2026-07-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
        </entity>
        <period>
            <startDate>2026-07-10</startDate>
            <endDate>2026-07-10</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-02-28_custom_CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_custom_CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-07-02_custom_CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-02</instant>
        </period>
    </context>
    <context id="From2026-07-022026-07-02_custom_CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400897</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">srv:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-02</startDate>
            <endDate>2026-07-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2026-07-10" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2026-07-10" id="Fact000004">424B2</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="AsOf2026-07-10" id="Fact000005">NXG Cushing Midstream Energy Fund</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-07-10" id="Fact000006">0001400897</dei:EntityCentralIndexKey>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2026-07-10" id="Fact000013">&lt;p id="xdx_801_ecef--PurposeOfFeeTableNoteTextBlock_dU_zlHuWSJm5d19" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;The following table contains information about the
costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of	 November 30, 2025 (except as noted below) after giving effect to the net proceeds from the issuance of 1,555,870 Common Shares
on December 18, 2025, pursuant to the exercise of transferrable rights issued by the Fund on November 17, 2025, and the anticipated net
proceeds of the Common Shares offered by this Prospectus Supplement and the accompanying Prospectus and assuming the Fund incurs the estimated
offering expenses. If the Fund issues fewer than all of the Common Shares available for sale pursuant to the Distribution Agreement and
the net proceeds to the Fund are less, all other things being equal, the total annual expenses shown would increase. The purpose of the
table and the example below is to help you understand the fees and expenses that you, as a holder of Common Shares, would bear directly
or indirectly.&lt;/p&gt;

</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2026-07-10" id="Fact000016">&lt;p id="xdx_803_ecef--ShareholderTransactionExpensesTableTextBlock_dU_gL1STETTB-SXSLEM_zO4E25wEIs2d" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 88%"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Shareholder Transaction Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-size: 11pt"&gt;Sales load (&lt;span id="xdx_903_ecef--BasisOfTransactionFeesNoteTextBlock_c20260710__20260710_zaAcZGvYoy4b"&gt;as a percentage of offering price&lt;/span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_909_ecef--SalesLoadPercent_c20260710__20260710_fKDEp_zNL2HI8Je5Aa"&gt;1.00%&lt;/span&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-size: 11pt"&gt;Offering expenses borne by the Fund (as a percentage of offering price)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_90A_ecef--OtherTransactionExpensesPercent_c20260710__20260710_fKDIp_z5jvZcRWr0J2"&gt;0.07%&lt;/span&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-size: 11pt"&gt;Dividend Reinvestment Plan fees (per transaction sales fee)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_909_ecef--DividendReinvestmentAndCashPurchaseFees_c20260710__20260710_fKDMp_zHdXLL4dEE1e"&gt;15.00&lt;/span&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F05_zifXoxg2bRKd"&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F1B_zIl4sOkWf9F9" style="text-align: left"&gt;Represents the estimated commission with respect to the Common
Shares being sold under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales
of Common Shares under this Prospectus Supplement and the accompanying Prospectus. Actual sales of Common Shares under this Prospectus
Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#x201c;Capitalization&#x201d; below. In addition,
the price per Common Share of any such sale may be greater or less than the price set forth under &#x201c;Capitalization&#x201d; below,
depending on market price of the Common Shares at the time of any such sale.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F06_z0jFuhm5JXL2"&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F1B_zAqzSWuh4FI7" style="text-align: left"&gt;Assumes offering expenses of $50,000 and the sale of 1,500,000
Common Shares at a sales price per Common Share of $49.00, which represents the last reported sales price of the Common Shares on the
NYSE on July 2, 2026. There is no guarantee that there will be any sales of Common Shares under this Prospectus Supplement and the accompanying
Prospectus. Actual sales, if any, of the Common Shares under this Prospectus Supplement and the accompanying Prospectus may be at a price
greater or less than $49.00 per Common Share, depending on the market price of the Common Shares at the time of any such sale.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F04_zFqtOKV3I0Pl"&gt;(3)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F1F_zEBzngqThSwe" style="text-align: left"&gt;&lt;span id="xdx_900_ecef--OtherTransactionFeesNoteTextBlock_c20260710__20260710_zQChTNDyDsd"&gt;There will be no brokerage charges with respect to Common Shares
issued directly by the Fund. However, each participant will pay a pro rata share of brokerage commissions incurred in connection with
open-market purchases. In addition, participants who request a sale of shares through the Plan Agent are subject to a $15.00 per transaction
sales fee and pay a brokerage commission of $0.12 per share sold. The Fund&#x2019;s transfer agent serves as Plan Agent. Fees paid by
the Fund to the transfer agent are included in &#x201c;Other expenses&#x201d; below, which are ultimately borne by common shareholders.
For additional information, see &#x201c;Dividend Reinvestment Plan&#x201d; in the accompanying Prospectus.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="AsOf2026-07-10" id="Fact000017">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000018"
      unitRef="Ratio">0.0100</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000019"
      unitRef="Ratio">0.0007</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2026-07-10"
      decimals="0"
      id="Fact000020"
      unitRef="USD">15.00</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2026-07-10" id="Fact000025">&lt;p id="xdx_803_ecef--AnnualExpensesTableTextBlock_dU_gRBAETTB-KSYYE_zW0nAdDEMZQe" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 65%"&gt;&lt;b&gt;Annual Expenses&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 35%; text-align: center"&gt;&lt;b&gt;Percentage of Net Assets&lt;br/&gt;
Attributable to Common Shares&lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-size: 11pt"&gt;Management fees&lt;sup&gt;(5)(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_904_ecef--ManagementFeesPercent_c20260710__20260710_fKDQpKDUpKDYp_zXYByo6hJ325"&gt;1.60%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-size: 11pt"&gt;Interest payments on borrowed funds&lt;sup&gt;(7)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_90D_ecef--InterestExpensesOnBorrowingsPercent_c20260710__20260710_fKDQpKDcp_zYjlkj5qxZD"&gt;1.27%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-size: 11pt"&gt;Other expenses&lt;sup&gt;(8)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_909_ecef--OtherAnnualExpensesPercent_c20260710__20260710_fKDQpKDgp_ztwZOx9W5z0a"&gt;0.65%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-left: 9pt"&gt;&lt;span style="font-size: 11pt"&gt;Total annual expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_901_ecef--TotalAnnualExpensesPercent_c20260710__20260710_fKDQp_ztyjoscOFdG8"&gt;3.52%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Fee Waiver&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_904_ecef--WaiversAndReimbursementsOfFeesPercent_c20260710__20260710_fKDQp_zn5AxLC1StC1"&gt;(0.32)%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Net annual expense (after fee waiver)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_907_ecef--NetExpenseOverAssetsPercent_c20260710__20260710_fKDQp_z77ag0BYrt0c"&gt;3.19%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F0A_zVXSGArzUpu"&gt;(4)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F1C_z0yrY1MC2Mkk" style="text-align: left"&gt;Based upon net assets attributable to Common Shares as of November 30, 2025
                                                                                                                  after giving effect to the net proceeds from the issuance of 1,555,870 Common Shares on December 18, 2025, pursuant to the exercise
                                                                                                                  of transferrable rights issued by the Fund on November 17, 2025, and the anticipated net proceeds of the Common Shares offered by
                                                                                                                  this Prospectus Supplement and the accompanying Prospectus and assuming the Fund incurs the estimated offering expenses.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F09_zL8cSjzVal6d"&gt;(5)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F15_zn7Ru3vfcVG5" style="text-align: left"&gt;The Fund pays the Investment Adviser an annual fee, payable monthly, in an
                                                                                                                   amount equal to 1.25% of the Fund&#x2019;s average weekly Managed Assets (net assets plus any assets attributable to financial leverage). The fee shown above is based upon outstanding financial leverage of 21% of the Fund&#x2019;s Managed Assets (or 27% of the
                                                                                                                   Fund&#x2019;s net assets attributable to common shares). If financial leverage of more than 21% of the Fund&#x2019;s Managed Assets
                                                                                                                   (or 27% of the Fund&#x2019;s net assets attributable to common shares) is used, the management fees, as a percentage of net assets
                                                                                                                   attributable to common shares, would be higher than as shown above.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F0C_zGoNQ88tSHqd"&gt;(6)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F10_zBzFP2OZFns2" style="text-align: left"&gt;The Investment Adviser has contractually agreed to waive a portion
of the management fee in an amount equal to 0.25% of the Fund&#x2019;s Managed Assets through November 12, 2026. The Fund&#x2019;s annual
expenses after giving effect to such management fee waiver are:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 65%"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Annual Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 35%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Percentage of Net Assets&lt;br/&gt;
Attributable to Common Shares&lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Management fees&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;1.60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Interest payments on borrowed funds&lt;sup&gt;(7)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;1.27%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Other expenses&lt;sup&gt;(8)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;0.65%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Total annual expenses (before fee waiver)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;3.52%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Fee Waiver&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;(0.32)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;Net annual expense (after fee waiver)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;3.19%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;/div&gt;&lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F02_zl8ONWOJKpSh"&gt;(7)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F12_zPb9E357KOq1" style="text-align: left"&gt;Based upon the Fund&#x2019;s outstanding borrowings as of November
30, 2025 of approximately $55 million and the interest rate as of November 30, 2025 of 4.62%.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&lt;sup&gt;&#160;&lt;/sup&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;sup id="xdx_F0D_z570VZvEdcm9"&gt;(8)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_F10_zFvQGZoS0tHf"&gt;&lt;span id="xdx_902_ecef--OtherExpensesNoteTextBlock_c20260710__20260710_z8vmZnCR0TX4"&gt;&#x201c;Other
                                            expenses&#x201d; are estimated based upon those incurred during the fiscal year ended November
                                            30, 2025. Other expenses do not include expense related to realized or unrealized investment
                                            gains or losses. See &#x201c;Additional Information (Unaudited)&#x2014;Management of the Fund&#x2014;Fund Expenses&#x201d; in the Annual Report.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000026"
      unitRef="Ratio">0.0160</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000027"
      unitRef="Ratio">0.0127</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000028"
      unitRef="Ratio">0.0065</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000029"
      unitRef="Ratio">0.0352</cef:TotalAnnualExpensesPercent>
    <cef:WaiversAndReimbursementsOfFeesPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000030"
      unitRef="Ratio">-0.0032</cef:WaiversAndReimbursementsOfFeesPercent>
    <cef:NetExpenseOverAssetsPercent
      contextRef="AsOf2026-07-10"
      decimals="INF"
      id="Fact000031"
      unitRef="Ratio">0.0319</cef:NetExpenseOverAssetsPercent>
    <cef:OtherTransactionFeesNoteTextBlock contextRef="AsOf2026-07-10" id="Fact000035">There will be no brokerage charges with respect to Common Shares
issued directly by the Fund. However, each participant will pay a pro rata share of brokerage commissions incurred in connection with
open-market purchases. In addition, participants who request a sale of shares through the Plan Agent are subject to a $15.00 per transaction
sales fee and pay a brokerage commission of $0.12 per share sold. The Fund&#x2019;s transfer agent serves as Plan Agent. Fees paid by
the Fund to the transfer agent are included in &#x201c;Other expenses&#x201d; below, which are ultimately borne by common shareholders.
For additional information, see &#x201c;Dividend Reinvestment Plan&#x201d; in the accompanying Prospectus.</cef:OtherTransactionFeesNoteTextBlock>
    <cef:OtherExpensesNoteTextBlock contextRef="AsOf2026-07-10" id="Fact000041">&#x201c;Other
                                            expenses&#x201d; are estimated based upon those incurred during the fiscal year ended November
                                            30, 2025. Other expenses do not include expense related to realized or unrealized investment
                                            gains or losses. See &#x201c;Additional Information (Unaudited)&#x2014;Management of the Fund&#x2014;Fund Expenses&#x201d; in the Annual Report.</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2026-07-10" id="Fact000043">&lt;p id="xdx_80C_ecef--ExpenseExampleTableTextBlock_dU_zRx3y4TvjoSe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Example&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;The following example illustrates the expenses that
you would pay on a $1,000 investment in Common Shares, assuming (1) &#x201c;Total annual expenses&#x201d; of 3.51%, (2) the sales load of
$735,000 and estimated offering expenses of $50,000, and (3) a 5% annual return*:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 52%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;3 Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;5 Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;10 Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td style="padding-left: 0.2in; text-indent: -0.2in"&gt;&lt;span style="font-size: 11pt"&gt;Total Expenses Incurred&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_900_ecef--ExpenseExampleYear01_c20260710__20260710_fKg_____zBkdofOS6DO2"&gt;46&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_900_ecef--ExpenseExampleYears1to3_c20260710__20260710_fKg_____zHvDLaTMzLz6"&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_909_ecef--ExpenseExampleYears1to5_c20260710__20260710_fKg_____zoZEEk0hr1G3"&gt;192&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_908_ecef--ExpenseExampleYears1to10_c20260710__20260710_fKg_____zhCe8RRc2eag"&gt;386&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0pt"&gt;&lt;/td&gt;&lt;td style="width: 20pt; text-align: left"&gt;&lt;b id="xdx_F02_zqeBtgxYdbp5"&gt;*&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b id="xdx_F12_zWO0Hff4QCV6"&gt;The example should not be considered a representation of future
expenses or returns. Actual expenses may be higher or lower than those assumed. Moreover, the Fund&#x2019;s actual rate of return may
be higher or lower than the hypothetical 5% return shown in the example. &lt;/b&gt;The example assumes that the estimated &#x201c;Other expenses&#x201d;
set forth in the Annual Expenses table are accurate and that all dividends and distributions are reinvested at net asset value.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"&gt;&lt;/p&gt;




</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2026-07-10"
      decimals="0"
      id="Fact000044"
      unitRef="USD">46</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2026-07-10"
      decimals="0"
      id="Fact000045"
      unitRef="USD">118</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2026-07-10"
      decimals="0"
      id="Fact000046"
      unitRef="USD">192</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2026-07-10"
      decimals="0"
      id="Fact000047"
      unitRef="USD">386</cef:ExpenseExampleYears1to10>
    <cef:SharePriceTableTextBlock contextRef="AsOf2026-07-10" id="Fact000050">&lt;p id="xdx_802_ecef--SharePriceTableTextBlock_dU_zbdxNF4vOrHl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Market Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Corresponding Net&lt;br/&gt;
Asset Value Per&lt;br/&gt;
Common Share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Corresponding&lt;br/&gt;
Premium/(Discount)&lt;br/&gt;
as a Percentage of &lt;br/&gt;
Net Asset Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; width: 24%"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Fiscal Quarter Ended&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: Gainsboro"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;February 28, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_90E_ecef--HighestPriceOrBid_c20251201__20260228__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_z2sIlVhnzcuk"&gt;43.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_902_ecef--LowestPriceOrBid_c20251201__20260228__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zkBIWolIQWI3"&gt;38.67&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_908_ecef--HighestPriceOrBidNav_c20251201__20260228__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zVpLnq8gdeVa"&gt;45.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_906_ecef--LowestPriceOrBidNav_c20251201__20260228__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zmMIGg3vtbV"&gt;40.14&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_904_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20251201__20260228__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zJMfXkVtfgg1"&gt;(2.94) %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_903_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20251201__20260228__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_z776DZ5A3Si5"&gt;(3.66) %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-size: 11pt"&gt;May 31, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_902_ecef--HighestPriceOrBid_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zuX6iBeOEgGa"&gt;50.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_908_ecef--LowestPriceOrBid_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zA3TtIF2dP08"&gt;42.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_90B_ecef--HighestPriceOrBidNav_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zEbgnrzKVSr2"&gt;52.48&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;$&lt;span id="xdx_90D_ecef--LowestPriceOrBidNav_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_z47eWp7dHXgi"&gt;45.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_90F_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_z0FOkJUjnVY5"&gt;(3.20) %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_90B_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zWzXaz45jzCb"&gt;(6.84) %&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2025-12-012026-02-28_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000051"
      unitRef="USDPShares">43.85</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-12-012026-02-28_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000052"
      unitRef="USDPShares">38.67</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-12-012026-02-28_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000053"
      unitRef="USDPShares">45.18</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-12-012026-02-28_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000054"
      unitRef="USDPShares">40.14</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-12-012026-02-28_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000055"
      unitRef="Ratio">-0.0294</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-12-012026-02-28_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000056"
      unitRef="Ratio">-0.0366</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2026-03-012026-05-31_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000057"
      unitRef="USDPShares">50.80</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2026-03-012026-05-31_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000058"
      unitRef="USDPShares">42.34</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2026-03-012026-05-31_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000059"
      unitRef="USDPShares">52.48</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2026-03-012026-05-31_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000060"
      unitRef="USDPShares">45.45</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2026-03-012026-05-31_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000061"
      unitRef="Ratio">-0.0320</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2026-03-012026-05-31_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000062"
      unitRef="Ratio">-0.0684</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2026-07-02_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000063"
      unitRef="USDPShares">47.02</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2026-07-02_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000064"
      unitRef="USDPShares">49.00</us-gaap:SharePrice>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="From2026-07-022026-07-02_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000065"
      unitRef="Ratio">0.0421</cef:LatestPremiumDiscountToNavPercent>
    <cef:OutstandingSecuritiesTableTextBlock contextRef="AsOf2026-07-10" id="Fact000067">&lt;p id="xdx_80F_ecef--OutstandingSecuritiesTableTextBlock_dU_z5WDTaxXpmoh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Outstanding Securities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;The following information regarding the Fund&#x2019;s
authorized shares is as of July 2, 2026:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="2" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 40%"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Title of Class&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Amount Authorized&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Amount Held by Fund&lt;br/&gt;
for its own Account&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;b&gt;Amount Outstanding&lt;br/&gt;
Exclusive of Amounts&lt;br/&gt;
held by Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: Gainsboro"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_902_ecef--OutstandingSecurityTitleTextBlock_c20260702__20260702__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zkytt4444BT5"&gt;Common Shares of Beneficial Interest&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;Unlimited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_907_ecef--OutstandingSecurityHeldShares_dn_c20260702__20260702__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zNbZL0JQuyMf"&gt;None&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&lt;span style="font-size: 11pt"&gt;&lt;span id="xdx_90B_ecef--OutstandingSecurityNotHeldShares_c20260702__20260702__us-gaap--StatementClassOfStockAxis__custom--CommonSharesMember_zQiunyYvlibe"&gt;6,234,375&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="From2026-07-022026-07-02_custom_CommonSharesMember"
      id="Fact000068">Common Shares of Beneficial Interest</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="From2026-07-022026-07-02_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000069"
      unitRef="Shares">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2026-07-022026-07-02_custom_CommonSharesMember"
      decimals="INF"
      id="Fact000070"
      unitRef="Shares">6234375</cef:OutstandingSecurityNotHeldShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnote id="Footnote000032" xlink:label="Footnote000032" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the estimated commission with respect to the Common
Shares being sold under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales
of Common Shares under this Prospectus Supplement and the accompanying Prospectus. Actual sales of Common Shares under this Prospectus
Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#x201c;Capitalization&#x201d; below. In addition,
the price per Common Share of any such sale may be greater or less than the price set forth under &#x201c;Capitalization&#x201d; below,
depending on market price of the Common Shares at the time of any such sale.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000033" xlink:label="Footnote000033" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Assumes offering expenses of $50,000 and the sale of 1,500,000
Common Shares at a sales price per Common Share of $49.00, which represents the last reported sales price of the Common Shares on the
NYSE on July 2, 2026. There is no guarantee that there will be any sales of Common Shares under this Prospectus Supplement and the accompanying
Prospectus. Actual sales, if any, of the Common Shares under this Prospectus Supplement and the accompanying Prospectus may be at a price
greater or less than $49.00 per Common Share, depending on the market price of the Common Shares at the time of any such sale.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnote id="Footnote000034" xlink:label="Footnote000034" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">There will be no brokerage charges with respect to Common Shares
issued directly by the Fund. However, each participant will pay a pro rata share of brokerage commissions incurred in connection with
open-market purchases. In addition, participants who request a sale of shares through the Plan Agent are subject to a $15.00 per transaction
sales fee and pay a brokerage commission of $0.12 per share sold. The Fund&#x2019;s transfer agent serves as Plan Agent. Fees paid by
the Fund to the transfer agent are included in &#x201c;Other expenses&#x201d; below, which are ultimately borne by common shareholders.
For additional information, see &#x201c;Dividend Reinvestment Plan&#x201d; in the accompanying Prospectus.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnote id="Footnote000036" xlink:label="Footnote000036" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based upon net assets attributable to Common Shares as of November 30, 2025
                                                                                                                  after giving effect to the net proceeds from the issuance of 1,555,870 Common Shares on December 18, 2025, pursuant to the exercise
                                                                                                                  of transferrable rights issued by the Fund on November 17, 2025, and the anticipated net proceeds of the Common Shares offered by
                                                                                                                  this Prospectus Supplement and the accompanying Prospectus and assuming the Fund incurs the estimated offering expenses.</link:footnote>
        <link:footnote id="Footnote000037" xlink:label="Footnote000037" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays the Investment Adviser an annual fee, payable monthly, in an
                                                                                                                   amount equal to 1.25% of the Fund&#x2019;s average weekly Managed Assets (net assets plus any assets attributable to financial leverage). The fee shown above is based upon outstanding financial leverage of 21% of the Fund&#x2019;s Managed Assets (or 27% of the
                                                                                                                   Fund&#x2019;s net assets attributable to common shares). If financial leverage of more than 21% of the Fund&#x2019;s Managed Assets
                                                                                                                   (or 27% of the Fund&#x2019;s net assets attributable to common shares) is used, the management fees, as a percentage of net assets
                                                                                                                   attributable to common shares, would be higher than as shown above.</link:footnote>
        <link:footnote id="Footnote000038" xlink:label="Footnote000038" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Investment Adviser has contractually agreed to waive a portion
of the management fee in an amount equal to 0.25% of the Fund&#x2019;s Managed Assets through November 12, 2026. The Fund&#x2019;s annual
expenses after giving effect to such management fee waiver are:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000037"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnote id="Footnote000039" xlink:label="Footnote000039" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based upon the Fund&#x2019;s outstanding borrowings as of November
30, 2025 of approximately $55 million and the interest rate as of November 30, 2025 of 4.62%.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000039"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnote id="Footnote000040" xlink:label="Footnote000040" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Other
                                            expenses&#x201d; are estimated based upon those incurred during the fiscal year ended November
                                            30, 2025. Other expenses do not include expense related to realized or unrealized investment
                                            gains or losses. See &#x201c;Additional Information (Unaudited)&#x2014;Management of the Fund&#x2014;Fund Expenses&#x201d; in the Annual Report.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000044"
          xlink:label="Fact000044"
          xlink:type="locator"/>
        <link:footnote id="Footnote000048" xlink:label="Footnote000048" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example should not be considered a representation of future
expenses or returns. Actual expenses may be higher or lower than those assumed. Moreover, the Fund&#x2019;s actual rate of return may
be higher or lower than the hypothetical 5% return shown in the example.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000044"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000045"
          xlink:label="Fact000045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000045"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000046"
          xlink:label="Fact000046"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000046"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000047"
          xlink:label="Fact000047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000047"
          xlink:to="Footnote000048"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
